يحاول ذهب - حر
PLI boost: Cancer drugs to cost less
March 05, 2025
|Mint Kolkata
Cancer patients facing prohibitive treatment costs in India can hope for relief.
The nation's top drugmakers have started manufacturing key medicines for such diseases in the country.
India's largest drugmaker Sun Pharmaceutical Industries Ltd and its peers Cipla Ltd, Glenmark Pharmaceuticals Ltd, Cadila Healthcare Ltd and Biocon Ltd are making cancer drugs under the production-linked incentive (PLI) scheme, according to information shared by the department of pharmaceuticals with Mint. They are among the 55 companies selected for incentives to produce 175 high-value medicines in India.
At present, most cancer drugs are imported, making them prohibitively expensive. That's when India's cancer burden is expected to rise from 26.7 million life years or DALYS―the sum of healthy life lost to a disease-in 2021 to 29.8 million in 2025, according to data from the Indian Council of Medical Research (ICMR) disability-adjusted The PLI scheme is a "great boon" as cancer drugs will not only become cheaper in India, but South American and southern African nations will also benefit, said Shyam Aggarwal, chairperson, medical oncology department at Sir Ganga Ram Hospital, Delhi.
هذه القصة من طبعة March 05, 2025 من Mint Kolkata.
اشترك في Magzter GOLD للوصول إلى آلاف القصص المتميزة المنسقة، وأكثر من 9000 مجلة وصحيفة.
هل أنت مشترك بالفعل؟ تسجيل الدخول
المزيد من القصص من Mint Kolkata
Mint Kolkata
With $2.2 bn fund, ChrysCap has appetite for riskier bets
MD Saurabh Chatterjee details shift in global LP base, renewed focus on manufacturing
3 mins
December 01, 2025
Mint Kolkata
Smart GDP growth casts shadow over December rate cut
The Reserve Bank of India’s (RBI's) Monetary Policy Committee (MPC) is widely expected to keep the policy rate unchanged on 5 December, even as a sizable minority of economists argues that the space created by softening inflation and moderating nominal growth warrants another rate cut.
1 min
December 01, 2025
Mint Kolkata
European stock markets dominate global rankings
In the ranks of the world’s 20 best-performing stock markets this year, every second index is European.
1 mins
December 01, 2025
Mint Kolkata
Data centers are a ‘gold rush’ for construction workers
Mond Chambliss used to run himself ragged with the small contracting business he owned in Columbus, Ohio: hanging drywall, chasing clients for payments and managing half a dozen employees.
4 mins
December 01, 2025
Mint Kolkata
Let chats stay easy
India’s Department of Telecommunications has directed messaging apps like WhatsApp to ensure that users aren't allowed to access these services without active SIM cards in their phones.
1 min
December 01, 2025
Mint Kolkata
As mid-cap alpha shrinks, should you consider passive strategies?
Advisers urge a balanced mix—add passives slowly and back strong, active managers, as mid-caps are still pricey
4 mins
December 01, 2025
Mint Kolkata
Let's be a bit more selective in using the word 'reforms'
Everybody should take a beat and think before uttering the word ‘reforms’ the next time. Glib usage, frequently in the wrong context, threatens to rob the word of its import.
3 mins
December 01, 2025
Mint Kolkata
India's regulated exports at risk: BCG
India’s export-driven businesses in sectors such as aluminium, iron and steel that face international regulatory shocks are increasingly exposed to risk due to climate inaction threatening their profits, operations, and long-term viability, according to global consulting firm BCG.
1 min
December 01, 2025
Mint Kolkata
Gen Z redefines work in a volatile job market
Amid layoffs, Gen Z is pushing back against overwork, choosing clear boundaries, sustainable growth over old notions of indispensability
3 mins
December 01, 2025
Mint Kolkata
No, our election booth level officers aren't dying of stress
A dangerous thing the Indian news media does is attribute reasons for suicide.
4 mins
December 01, 2025
Listen
Translate
Change font size

